University of Louisville
Playback speed
10 seconds
Using Cellular Immunotherapies to Induce Durable Objective Responses in Cancer Patients
By
University of Louisville
FEATURING
Jason Chesney
By
University of Louisville
FEATURING
Jason Chesney
30 views
May 18, 2023
Jason A. Chesney, M.D., Ph.D., Professor of Medicine, Pharmacology and Toxicology, Biochemistry and Molecular Biology; ...
read more ↘ Chief, Division of Medical Oncology and Hematology; James Graham Brown Foundation Chair; Associate Vice President for Health Affairs; Director and Chief Administrative Officer, UofL Health - James Graham Brown Cancer Center; and Co-Director, Center for Cancer Immunology and Immunotherapy at the University of Louisville School of Medicine, focused on understanding the concept of using the immune system to induce objective responses in cancer patients, recognizing the clinical utility of Tumor Infiltrating Lymphocytes (TILs) for the treatment of multiple types of cancer, and discussing the clinical utility of Chimeric Antigen Receptor (CAR) T cells for the treatment of multiple types of cancer.
↖ read less
read more ↘ Chief, Division of Medical Oncology and Hematology; James Graham Brown Foundation Chair; Associate Vice President for Health Affairs; Director and Chief Administrative Officer, UofL Health - James Graham Brown Cancer Center; and Co-Director, Center for Cancer Immunology and Immunotherapy at the University of Louisville School of Medicine, focused on understanding the concept of using the immune system to induce objective responses in cancer patients, recognizing the clinical utility of Tumor Infiltrating Lymphocytes (TILs) for the treatment of multiple types of cancer, and discussing the clinical utility of Chimeric Antigen Receptor (CAR) T cells for the treatment of multiple types of cancer.
↖ read less
Comments 0
Login to view comments.
Click here to Login